SynthesisDrug safety2018

Potential Risks Related to Modulating Interleukin-13 and Interleukin-4 Signalling: A Systematic Review.

Martin Braddock et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.